Table 1 Demographics of included patients with chronic aortic regurgitation.

From: Phase contrast CMR in the descending aorta as a supportive reference for severe aortic regurgitation

 

All patients

(n = 191)

Cohort 1

(n = 41)

Cohort 2

(n = 146)

p-value

Age (y)

49 ± 17

52 ± 15

48 ± 17

0.284

Sex, female (n(%))

53(28)

7(17)

46(32)

0.071

BSA (m2)

2 ± 0.2

2 ± 0.2

2 ± 0.2

0.375

Heart rate (beats/min)

66 ± 11

61 ± 9

67 ± 12

0.007

Systolic BP (mm Hg)

137 ± 20

136 ± 23

137 ± 19a

0.560

Diastolic BP (mmHg)

70 ± 15

68 ± 13

72 ± 15a

0.235

BAV (n(%))

75(40)

22(54)

53(36)

0.033

Concomitant AS (n(%))

16(9)

0

16(11)

0.030

LVEF (%)

55 ± 10

58 ± 7

55 ± 11

0.089

LVEDV (mL)

253 ± 86

309 ± 87

237 ± 80

< 0.001

LVESV (mL)

117 ± 57

132 ± 50

113 ± 58

0.016

LVSV (mL)

136 ± 46

177 ± 46

124 ± 39

< 0.001

  1. Data presented as mean ± standard deviation (SD). Significance is presented as p-value. AS: aortic stenosis, BAV: bicuspid aortic valve, BSA: body surface area, BP: blood pressure, EF: ejection fraction, LVEDV: left ventricular end diastolic volume, LVESV: left ventricular end diastolic volume.
  2. a Data from 71 patients.